Sign Up to like & get
recommendations!
0
Published in 2020 at "Vaccines"
DOI: 10.3390/vaccines8030447
Abstract: Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over…
read more here.
Keywords:
hepatocellular carcinoma;
immuno oncotherapeutic;
approaches advanced;
advanced hepatocellular ... See more keywords